E. I. du Pont de Nemours and Company (DuPont) - 2000 10-K Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2000. DuPont is a global science and technology leader operating through approximately 20 strategic business units aggregated into nine reportable segments: Agriculture & Nutrition, Nylon Enterprise, Performance Coatings & Polymers, Pharmaceuticals, Pigments & Chemicals, Pioneer, Polyester Enterprise, Specialty Fibers, and Specialty Polymers. The company operates in about 70 countries, with approximately 49% of consolidated sales generated outside the United States. Total worldwide employment at year-end 2000 was approximately 93,000.
The company completed the divestiture of its petroleum business, Conoco Inc., in August 1999; this business is reported as discontinued operations.
Key Financial Metrics
Note: Specific numerical values for revenue, profit, cash flow, and margins are not provided in the text of this filing. The document states that detailed financial data is incorporated by reference to the 2000 Annual Report to Stockholders (Exhibit 13).
- Revenue & Profit: Specific figures for net sales, operating income, and net income are located in Exhibit 13 (pages 68-71 for segment data; page 73 for five-year review).
- Cash Flow & Liquidity: Consolidated Statement of Cash Flows and liquidity details are in Exhibit 13 (pages 45 and 27-29).
- Debt: Specific debt levels are not listed in this text; instruments defining long-term debt rights are available upon request (Exhibit 4).
- Market Capitalization: As of March 7, 2001, the aggregate market value of voting stock held by nonaffiliates was approximately $49.2 billion.
- Shares Outstanding: 1,042,698,606 shares of common stock were outstanding as of March 7, 2001 (excluding 87,041,427 treasury shares).
- Capacity Utilization: Sales as a percent of capacity were 81% in 2000 (compared to 83% in 1999 and 82% in 1998).
Material Changes and Operational Highlights
- Acquisitions: On October 1, 1999, DuPont acquired the remaining ~80% of Pioneer Hi-Bred International for $7,684 million, making it a wholly-owned subsidiary.
- Discontinued Operations: The petroleum business (Conoco) was fully divested in 1999 and is no longer part of continuing operations.
- Segment Performance Drivers:
- Pioneer: Highly seasonal; sales and earnings are concentrated in the first half of the year. Inventory peaks at year-end.
- Pharmaceuticals: Ten wholesale distributors comprised 62% of gross sales in 2000.
- Raw Materials: A substantial portion of sales (excluding Pharmaceuticals and Pioneer) depends on hydrocarbon feedstocks. Costs for petroleum-based feedstocks, natural gas, and paraxylene are key variables.
- Intellectual Property: The company holds nearly 21,000 worldwide patents and 2,400 trademarks. Key pharmaceutical patents for Sustiva expire in 2013/2014, and Cozaar/Hyzaar patents expire in 2009.
Guidance, Risks, and Contingencies
Legal Proceedings and Contingencies:
- Benlate(R) Litigation: Approximately 120 lawsuits remain pending regarding alleged crop damage from Benlate(R) 50 DF. A Texas jury awarded damages totaling approximately $35 million (after statutory reduction) in a 2000 case; DuPont is appealing. Management does not anticipate a material adverse effect on consolidated financial position but notes potential significance to the Agriculture & Nutrition segment.
- Environmental Matters:
- Wurtland, KY: Settled a DOJ suit regarding an oleum release for a penalty of $850,000 plus $650,000 for an emergency planning system.
- Louisville, KY: DOJ proposed a $1.7 million fine for a 1997 hydrogen fluoride release; DuPont is contesting the fine as excessive.
- Grand Calumet River: DuPont is one of 17 potentially responsible parties (PRPs) for natural resource damage assessment; negotiations are ongoing.
- Pioneer/Monsanto Disputes:
- YieldGard(R) Corn: A jury found Pioneer breached a 1993 agreement with Monsanto, terminating the agreement. However, the court ruled Monsanto was not entitled to past damages. DuPont is appealing. An agreement allows Pioneer to continue selling the product pending the outcome.
- Roundup Ready(R) Soybeans: Monsanto sued to terminate a 1992 license agreement, alleging DuPont's acquisition of Pioneer constituted a breach. The case is in early stages.
- Financial Impact: Adverse outcomes in these lawsuits could result in impairment of intangible assets recorded for the license agreements, leading to one-time noncash charges.
Forward-Looking Risks:
- Raw Material Costs: Inability to offset higher costs of petroleum-based feedstocks through price increases.
- Regulatory & Product Development: Delays in FDA approvals or failure to gain market acceptance for new products.
- Global Operations: Exposure to foreign currency fluctuations, inflation, and changes in laws in 70+ countries.
- Environmental Compliance: Significant and ongoing costs associated with complex environmental laws and potential liability accruals.
Investor Verification Checklist
- Financial Statements: Verify specific revenue, net income, and cash flow figures in the 2000 Annual Report to Stockholders (Exhibit 13), as they are not explicitly listed in this 10-K text.
- Segment Performance: Review segment-specific sales and operating income in Exhibit 13 (pages 68-71) to understand the impact of the Pioneer acquisition and seasonal agricultural trends.
- Legal Exposure: Monitor the status of the Benlate(R) litigation and the Pioneer/Monsanto patent disputes, as adverse rulings could trigger significant noncash impairment charges.
- Environmental Liabilities: Assess the adequacy of accruals for environmental remediation, particularly regarding the Grand Calumet River and ongoing DOJ settlements.
- Pharmaceutical Pipeline: Evaluate the timeline for patent expirations on key drugs (Sustiva, Cozaar) and the progress of the R&D pipeline mentioned in the Pharmaceuticals segment review.